USD 2.8 billion
Report ID:
SQMIG25AD2015 |
Region:
Global |
Published Date: February, 2025
Pages:
189
|Tables:
91
|Figures:
71
Global IVF Devices and Consumables Market size was valued at USD 2.8 billion in 2023 and is poised to grow from USD 3.33 billion in 2024 to USD 13.5 billion by 2032, growing at a CAGR of 19.1% during the forecast period (2025-2032).
The global IVF devices and consumables industry is growing due to the prevalence of infertility coupled with delayed pregnancies, which arise from lifestyle change and aging.
The global IVF devices and consumables market has experienced significant growth due to advances in assisted reproductive technologies (ART) and an increasing number of individuals and couples seeking fertility treatments. IVF involves fertilizing an egg outside the body and then implanting the fertilized embryo in the uterus. The global IVF devices and consumables market, therefore, comprises both devices used in the IVF process and consumables used, which includes culture media, catheters, and needles. The driving factors behind this market are rising cases of infertility, delayed pregnancies, and changed lifestyles, among other factors. Acceptance of fertility treatments across the globe has increased.
Technological advancements have been a critical driver of market expansion, with innovations in IVF equipment such as incubators, embryo culture systems, ultrasound systems, and cryopreservation systems enhancing the success rates of IVF procedures. The advanced consumables of IVF, which include culture media, sperm-processing kits, and embryo transfer catheters, also have improved the outcomes, driving the market even further. More focus on individualized IVF treatments and more advanced diagnostic tools have improved the care of the patients and therefore the success rate.
Increasing fertility clinics and healthcare infrastructure in emerging markets in recent times, rising fertility clinics and growing healthcare infrastructure within emerging markets have contributed to the current growth of the market. As the demand for IVF procedures will persist, the demand for advanced IVF devices and consumables should also remain high as governments provide support through policies and coverage of health insurance for fertility treatments.
Acceptance of ART in society and integration into mainstream healthcare systems are factors that are fueling the global IVF devices and consumables market. The trends of increasing single parenthood, the desire of LGBTQ+ couples to undergo IVF services, and the aging population create a need for IVF solutions, thus creating a momentum in the market. This sector will continue to carry out investments in research and development, thus setting it up for added innovations and expansion in the coming years.
Key Market Attributes
In December 2024, CooperSurgical, one of the major providers of women's health solutions, launched its new range of advanced IVF devices that come with AI support for embryo assessment. These systems use AI, with the primary purpose of more accurate embryo selection and, hence, better IVF treatment results. This will dramatically make the IVF process smoother and the cost per cycle cheaper, hence opening IVF up to a larger group of patients in the next years, especially in developing countries with increasing health care infrastructure.
In November 2024, Vitrolife, one of the leaders in the IVF consumables market, unveiled its new and improved embryo culture media, developed for specific patient needs. Enhanced media formulations are designed to increase embryo viability and optimize culture conditions, thus improving the success rate of IVF procedures. Over the next 4-5 years, these are expected to considerably impact IVF success rates since there is increasingly high demand for high-quality consumables. Over the next decade, this shall pave the way for more personal treatment and develop the market within both developed and emerging economies.
Merck Group invested in the development of next-generation IVF equipment integrating CRISPR gene-editing technology for embryo screening. The breakthrough reduces the risks of genetic disorders through more accurate genetic testing for embryos, and it happened in September 2024. Such advances in genetic screening will thus propel the transformation of the IVF market for the next ten years, through safer and effective treatments, that meet the needs of a world where genetic testing and fertility are on the upsurge globally.
In August 2024, Ferring Pharmaceuticals released a new product line for consumables in IVF that provides individualized hormone therapy solutions with an aim of increasing embryo implantation rates. Such products will transform the course of IVF treatment protocols within the next ten years with a robust support system through comprehensive clinical trials. As personalized medicine keeps gaining grounds, these developments are likely to continue driving substantial growth in the market, especially as markets become concentrated on advanced reproductive technologies to make IVF ever more precise, accessible, and affordable in the future.
Market snapshot - 2025-2032
Global Market Size
USD 2.8 billion
Largest Segment
Fertility Clinics
Fastest Growth
Hospitals
Growth Rate
19.1% CAGR
To get more reports on the above market click here to Buy The Report
Global IVF Devices and Consumables Market is segmented by Product Type, Technology, End-User and region. Based on Product Type, the market is segmented into Instruments, Accessories and Disposables and Reagents and Media. Based on Technology, the market is segmented into Fresh Embryo IVF, Frozen Embryo IVF and Donor Egg IVF. Based on End-User, the market is segmented into Clinical Research Institutes, Fertility Clinics, Hospitals and Surgical Centers. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.
Analysis by End User
As per categorization by end user, the market is classified as clinical research institutes, fertility clinics, hospitals, and surgical centers. Among these, fertility clinics earned the largest share and continues to hold the dominant global IVF devices and consumables market share. Fertility clinics take the lead within the global IVF devices and consumables market and adopt the use of advanced technology, such as AI for selecting embryos, screening tools for genetics, and better cryopreservation systems. With an increased requirement for specialized treatments for fertility problems, higher procedure success rates, and a surge in the patient base looking up to IVF solutions, this segment leads in the market share. Fertility clinics offer customized care and therefore ensure optimal results, and thus they are the primary end user in the IVF market.
Hospitals are poised to become the fastest-growing end user in the global IVF devices and consumables market due to several factors. Rising development of healthcare infrastructure, especially in developing countries, is allowing hospitals to provide advanced fertility treatments alongside other medical facilities. Increasing adoption of IVF as a conventional fertility solution along with advancements in IVF technology and a rising demand for integrated healthcare systems is pushing the demand for more IVF-related equipment and consumables among hospitals. Hospitals have become an essential player in the expanding IVF market within the coming years, where many patients will be attracted to them in the case, they offer multidisciplinary care and quality services.
Analysis by Product
Accessories and disposables are crucial components driving the growth of the global IVF devices and consumables market. Some of the recent innovations in this segment include advanced embryo transfer catheters, culture media, and specialized needles that can improve the success rate of IVF and patient safety. These products are critical to optimizing the IVF procedure, offering better precision and reducing the risk of complications. The dominance of accessories and disposables can be attributed to the fact that they play a very critical role in every IVF cycle, they are relatively low-cost compared to high-tech equipment, and their usage is repetitive, making them an indispensable part of fertility treatments globally.
Instruments are expected to be the fastest-growing product segment in the global IVF devices and consumables market due to advancements in precision technology and increasing demand for higher success rates in IVF procedures. Adoption of sophisticated apparatus, including the culture of an embryo, cryopreservation device, and imaging devices aided by artificial intelligence is highly upgrading IVF procedures through increasing the success rates along with improved time and cost-efficiency in relation to treatment time and expense for healthcare centers that concentrate on high performance, lower treatment duration and expenses in cases of IVF, so their requirement for modern tools is constantly rising in future.
To get detailed analysis on other segments, Request For Free Sample Report
North America holds the largest share in the global IVF devices and consumables market, leading the health care structure, fertility treatment awareness, and access to advanced IVF technologies. The United States is prominent in this region, holding wide ranges of fertility clinics, coupled with relentless investments in research and development for the advancement of the sector.
U.S. is the dominant within the North American region in the global IVF devices and consumables market, due to the rising acceptability and access of fertility treatments since they are covered under insurance and government initiatives. Another factor is the presence of some key industry players and the on-going technological development, which makes the country a leader in the market.
Europe is the fastest-growing region for global IVF devices and consumables market, mainly attributed to growing demands for fertility treatments, better healthcare infrastructure, and positive government policies. The UK, Germany, and France are growing rapidly as countries that are up-adopting developed IVF technologies to experience such growth in the market.
Government support for fertility treatments, partly by reimbursing partial costs through the National Health Service (NHS), has fueled the dominance of IVF in the UK. In addition, increased consciousness regarding fertility preservation and innovative technological advancements that are being made in IVF procedures raise the accessibility and effectiveness of such treatments in the country.
The Asia-Pacific region is growing very fast in the global IVF devices and consumables market as a result of fertility awareness, increase in disposable incomes, and improvement in health infrastructure. China, India, and Japan are experiencing an increase in demand for fertility treatment procedures as they are supported by better technologies in the treatment procedure itself and government initiatives. Moreover, there is a strong growth in acceptance of assisted reproductive technologies and increases in fertility clinics, which would propel the growth of the market in this region.
In terms of geographical trends, the global IVF devices and consumables market is being expanded gradually in the MEA region due to the rising awareness of fertility treatments and better improvement in healthcare facilities. The IVF service is increasing in these countries such as the UAE, Saudi Arabia, and South Africa due to advanced access and rapid growth in medical tourism. The rising investment in healthcare in the region, coupled with favorable regulations, will also boost market growth in IVF treatments.
South America is growing steadily in the global IVF devices and consumables market with improving health infrastructure, increased awareness of fertility, and increased demand for reproductive technologies. Leaders in the market are Brazil, Argentina, and Chile, as the number of fertility clinics increases, and more patients apply for the IVF treatment. Expanding government initiatives toward providing fertility services, health insurance coverage, along with technological innovations, are promoting IVF adoption in the region with devices and consumables.
To know more about the market opportunities by region and country, click here to
Buy The Complete Report
Drivers
Increasing Infertility Rates
Technological Advancements in IVF
Restraints
Ethical and Social Concerns
Strict Regulatory Challenges
Request Free Customization of this report to help us to meet your business objectives.
The global IVF devices and consumables market is highly competitive, with key players focusing on technological advancements, product innovations, and strategic partnerships to maintain market share. CooperSurgical, Merck Group, Vitrolife, Ferring Pharmaceuticals, and Thermo Fisher Scientific are some of the major market players. Such companies are researching and developing more products, adding to their existing portfolios, and improving their supply chains to help them meet increasing demand for IVF treatments throughout the world.
Top Player’s Company Profiles
Recent Developments
SkyQuest’s ABIRAW (Advanced Business Intelligence, Research & Analysis Wing) is our Business Information Services team that Collects, Collates, Correlates, and Analyses the Data collected by means of Primary Exploratory Research backed by robust Secondary Desk research.
As per SkyQuest analysis, the global IVF devices and consumables market is experiencing robust growth, driven by factors such as rising infertility rates, technological advancements, and increasing societal acceptance of assisted reproductive technologies. Improvements in IVF equipment and consumables, from AI-assisted embryo evaluation to more advanced culture media and tools for genetic screening, are profoundly boosting success rates and making treatments available to far greater numbers.
As demand will be continuously on the rise, particularly in the emerging markets, it is believed that the market will continue to expand further. Improved health infrastructure and personalized treatments will propel growth within the IVF market and make the IVF sector continually evolve. IVF looks bright and holds promising trends as changes occur with respect to technology and societal conditions.
Report Metric | Details |
---|---|
Market size value in 2023 | USD 2.8 billion |
Market size value in 2032 | USD 13.5 billion |
Growth Rate | 19.1% |
Base year | 2024 |
Forecast period | 2025-2032 |
Forecast Unit (Value) | USD Billion |
Segments covered |
|
Regions covered | North America (US, Canada), Europe (Germany, France, United Kingdom, Italy, Spain, Rest of Europe), Asia Pacific (China, India, Japan, Rest of Asia-Pacific), Latin America (Brazil, Rest of Latin America), Middle East & Africa (South Africa, GCC Countries, Rest of MEA) |
Companies covered |
|
Customization scope | Free report customization with purchase. Customization includes:-
|
To get a free trial access to our platform which is a one stop solution for all your data requirements for quicker decision making. This platform allows you to compare markets, competitors who are prominent in the market, and mega trends that are influencing the dynamics in the market. Also, get access to detailed SkyQuest exclusive matrix.
Buy The Complete Report to read the analyzed strategies adopted by the top vendors either to retain or gain market share
Table Of Content
Executive Summary
Market overview
Parent Market Analysis
Market overview
Market size
KEY MARKET INSIGHTS
COVID IMPACT
MARKET DYNAMICS & OUTLOOK
Market Size by Region
KEY COMPANY PROFILES
Methodology
For the IVF Devices and Consumables Market, our research methodology involved a mixture of primary and secondary data sources. Key steps involved in the research process are listed below:
1. Information Procurement: This stage involved the procurement of Market data or related information via primary and secondary sources. The various secondary sources used included various company websites, annual reports, trade databases, and paid databases such as Hoover's, Bloomberg Business, Factiva, and Avention. Our team did 45 primary interactions Globally which included several stakeholders such as manufacturers, customers, key opinion leaders, etc. Overall, information procurement was one of the most extensive stages in our research process.
2. Information Analysis: This step involved triangulation of data through bottom-up and top-down approaches to estimate and validate the total size and future estimate of the IVF Devices and Consumables Market.
3. Report Formulation: The final step entailed the placement of data points in appropriate Market spaces in an attempt to deduce viable conclusions.
4. Validation & Publishing: Validation is the most important step in the process. Validation & re-validation via an intricately designed process helped us finalize data points to be used for final calculations. The final Market estimates and forecasts were then aligned and sent to our panel of industry experts for validation of data. Once the validation was done the report was sent to our Quality Assurance team to ensure adherence to style guides, consistency & design.
Analyst Support
Customization Options
With the given market data, our dedicated team of analysts can offer you the following customization options are available for the IVF Devices and Consumables Market:
Product Analysis: Product matrix, which offers a detailed comparison of the product portfolio of companies.
Regional Analysis: Further analysis of the IVF Devices and Consumables Market for additional countries.
Competitive Analysis: Detailed analysis and profiling of additional Market players & comparative analysis of competitive products.
Go to Market Strategy: Find the high-growth channels to invest your marketing efforts and increase your customer base.
Innovation Mapping: Identify racial solutions and innovation, connected to deep ecosystems of innovators, start-ups, academics, and strategic partners.
Category Intelligence: Customized intelligence that is relevant to their supply Markets will enable them to make smarter sourcing decisions and improve their category management.
Public Company Transcript Analysis: To improve the investment performance by generating new alpha and making better-informed decisions.
Social Media Listening: To analyze the conversations and trends happening not just around your brand, but around your industry as a whole, and use those insights to make better Marketing decisions.
Global IVF Devices and Consumables Market size was valued at USD 2.2 Billion in 2023 poised to grow from USD 2.61 Billion in 2024 to USD 10.14 Billion by 2032, growing at a CAGR of 18.5% in the forecast period (2025-2032).
The global IVF devices and consumables market is highly competitive, with key players focusing on technological advancements, product innovations, and strategic partnerships to maintain market share. CooperSurgical, Merck Group, Vitrolife, Ferring Pharmaceuticals, and Thermo Fisher Scientific are some of the major market players. Such companies are researching and developing more products, adding to their existing portfolios, and improving their supply chains to help them meet increasing demand for IVF treatments throughout the world. 'CooperSurgical (USA)', 'Vitrolife (Sweden)', 'Merck Group (Germany)', 'Ferring Pharmaceuticals (Switzerland)', 'Thermo Fisher Scientific (USA)', 'Genea Biomedx (Australia)', 'Irvine Scientific (USA)', 'Merck KGaA (Germany)', 'EMD Serono (USA/Switzerland)', 'Cook Medical (USA)', 'Smiths Medical (USA)', 'Labcorp Women’s Health (USA)', 'BioMérieux (France)', 'NOVA Biomedical (USA)', 'Ovum Biosciences (India)'
The rising prevalence of infertility, influenced by factors such as delayed pregnancies, lifestyle changes, and environmental factors, is a major driver for the IVF devices and consumables market. There is an increased number of people and couple seeking fertility treatment, and relatedly, there is a growing demand for higher IVF technologies and consumables.
Shift Towards Personalized IVF Treatments: The demand for personalized IVF treatments is significantly growing as advancements in genetic screening and artificial intelligence (AI) improve the customization of IVF procedures. Fertility clinics have increasingly embraced the use of technology that offers tailoring of treatment to an individual's genetic profile, which improves success rates. This way, it improves the outcome of a patient, limits the possibility of multiple cycles, and thus leads to cost effectiveness. Personalized treatments are increasingly driving the global IVF devices and consumables market trends, satisfying the increased need for effective fertility solutions.
North America holds the largest share in the global IVF devices and consumables market, leading the health care structure, fertility treatment awareness, and access to advanced IVF technologies. The United States is prominent in this region, holding wide ranges of fertility clinics, coupled with relentless investments in research and development for the advancement of the sector.
Want to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.
Feedback From Our Clients
Report ID: SQMIG25AD2015
[email protected]
USA +1 351-333-4748